Access company data including market activity, funding rounds, last funding round price-per-share and valuation milestones. Use proprietary Forge Price data to track performance and monitor how company value changes over time.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| PeerStreet | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $123.2M | Series C | 10/28/2019 | $65M | $342.1M | $4.32 | Colchis Capital, Andreessen Horowitz, World Innovation Lab, Thomvest Ventures | |||||
| Pepperdata | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $20.12M | Series A-1 | 2/22/2022 | $13M | $20.16M | $0.08 | Decathlon Capital Partners | |||||
| Pharmazz | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $43.22M | Series A | 6/11/2025 | $25M | $216.61M | $5.89 | Sun Pharma | |||||
| PlexTrac | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $83.47M | Series B | 2/2/2022 | $60M | $291.38M | $10.15 | Insight Partners, Madrona Venture Group, Noro-Moseley Partners, StageDotO Ventures | |||||
| Protego Trust Bank | Fintech Blockchain Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70M | Series A-5 | 7/1/2021 | $67.25M | $440.15M | $17.11 | FTX, Coinbase, Algorand, Avalanche, Cardano, Ripple, Solana, Digital Currency Group, NYCA Partners, Reciprocal Ventures | |||||
| Rainmaker | Missing Missing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $109.64M | Series B-5 | 9/20/2026 | $36.12M | $354.11M | $9.66 | NOA VC, Upfront Ventures, DCVC, Lowercarbon Capital, Dream Ventures | |||||
| Read AI | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $81M | Series B | 10/28/2024 | $50M | $432.09M | $22.65 | Smash Capital, Madrona, Goodwater Capital | |||||
| Realtime Robotics | Industrial Robotics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $68.97M | Series B | 5/24/2024 | $21.22M | $191.06M | $1.00 | Mitsubishi Electric Corporation | |||||
| Renew Financial | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $20M | Series Q | 8/11/2023 | $20M | $24.42M | $0.09 | Undisclosed Investors | |||||
| Ring Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $229.04M | Series D | 3/4/2026 | $50M | $300.05M | $2.06 | Undisclosed Investors | |||||
| Sambazon | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $84.21M | Series F-3 | 10/3/2025 | $45M | $319.25M | $1.15 | Undisclosed Investors | |||||
| Sapiom | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $47.94M | Series A-1 | 8/5/2026 | $32.62M | $284.15M | $15.16 | Dragonfly, Accel, Gradient, Coinbase Ventures, Operator Collective, Formus Capital, VanEck Ventures, Okta Ventures, Menlo Ventures, Anthropic, Array Ventures | |||||
| Seegrid | Industrial Robotics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $168.23M | Series D | 9/5/2024 | $50M | $277.18M | $2.82 | Giant Eagle, G2VP | |||||
| Selector | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $92.19M | Series B-2 | 2/18/2026 | $26.04M | $375M | $4.93 | AVP, Ansa Capital, Two Bear Capital, SineWave Ventures, Singtel Innov8 | |||||
| SetPoint Medical | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $302.51M | Series D | 10/28/2025 | $115.5M | $471.52M | $1.51 | Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest Venture Partners, New Enterprise Associates, Viking Global Investors, Action Potential Venture Capital, Abbott, Boston Scientific, Euclidean Capital, Richard King Mellon Foundation, Morgenthaler Ventures, ShangBay Capital, Ascendum Capital, Catalio Capital Management, Gilmartin Capital, Midas Capital | |||||
| Singularity | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.59M | Series A-1 | 7/14/2026 | $74.72M | $400M | $11.53 | Khosla Ventures, Felicis, AE Ventures, NEA, Long Journey, Harpoon, Menlo Ventures, Y Combinator, Decisive Point, New Vista Capital, Sunflower Capital, Soma Capital | |||||
| SkyKick | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $128.58M | Series B | 9/14/2021 | $65M | $443.87M | $9.51 | Morgan Stanley, Navin Thukkaram, Craig Nerenberg, Hawk Capital, Trebuchet Capital, Schechter Capital | |||||
| Solid | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $99.33M | Series B | 8/31/2022 | $2M | $303.02M | $2.40 | FTV Capital, Headline | |||||
| Soylent | Foodtech Animal-Free Protein | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $71.84M | Series B | 5/4/2017 | $50M | $373.08M | $2.31 | GV, Tao Capital Partners, Lerer Hippeau Ventures, Andreessen Horowitz | |||||
| Standard Template Labs | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $49M | Series Seed-2 | 3/17/2026 | $39M | $289.95M | $2.05 | ICONIQ Capital, CRV | |||||
| Survios | Industrial Augmented / Virtual Reality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $8.51M | Series A-1 | 2/25/2025 | $8.51M | $17.07M | $2.13 | Undisclosed Investors | |||||
| ThayerMahan | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $56.14M | Series C-3 | 1/9/2024 | $20M | $279.23M | $7.67 | Hanwha Asset Management, MC2, AE Industrial, I Squared Capital, Yellow Sub Funding | |||||
| Timberlyne Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $9.88M | Series A | 1/9/2025 | $9.37M | $137.37M | $3.64 | Abingworth, Bain Capital Life Sciences, Venrock, Boyu Capital, Lilly Asia Ventures, Braidwell, 3H Health Investment | |||||
| Tomorrow Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $92.06M | Series B | 6/29/2022 | $60M | $380.93M | $8.96 | BOND, Andreessen Horowitz, Obvious Ventures, BoxGroup, Sound Ventures | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.